Table of Contents
CHAPTER 1 US LAWS
- 1.1 The laws
- 1.1.1 The Food, Drug, and Cosmetic Act of 1938
- 1.1.2 The Administrative Procedures Act of 1946
- 1.1.3 Generic Animal Drug and Patent Term Restoration Act of 1988
- 1.1.4 Animal Medicinal Drug Use Clarification Act of 1994
- 1.1.5 Animal Drug Availability Act of 1996
- 1.1.6 The Food and Drug Administration Modernization Act of 1997
- 1.1.7 Animal Drug User Fee Act of 2002
- 1.1.8 Minor Use and Minor Species Animal Health Act of 2004
- 1.2 US Pharmacopoeia
CHAPTER 2 FDA REGULATIONS
- 2.1 Title 21 Code of Federal Regulations Part 25 (21 CFR 25)
- 2.2 Title 21 Code of Federal Regulations Part 58 (21 CFR 58)
- 2.3 Title 21 Code of Federal Regulations Part 210 (21 CFR 210)
- 2.4 Title 21 Code of Federal Regulations Part 500 (21 CFR 500)
CHAPTER 3 FDA GUIDANCE DOCUMENTS AND GUIDELINES
CHAPTER 4 ACCESS TO US MATERIALS
- 4.1 FOI Summaries
- 4.2 The laws
- 4.3 The regulations
- 4.4 Guidance documents
- 4.5 Concluding remarks
CHAPTER 5 GENERIC PRODUCTS
- 5.1 Background to the legislation
- 5.2 Abbreviated New Drug Applications
- 5.3 Patent term restoration
- 5.4 Provisions for animal drugs
CHAPTER 6 REGULATORY PROCESS FOR GENERIC ANIMAL DRUGS
CHAPTER 7 APPROVAL REQUIREMENTS FOR THE ANADA
CHAPTER 8 PRODUCT VARIATIONS PERMITTED UNDER THE GADPTRA
- 8.1 Suitability Petition
- 8.2 Hybrid Application
|
Related Report
|